טוען...
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few fractions with high single-fraction and total...
שמור ב:
| הוצא לאור ב: | Clin Transl Radiat Oncol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6630187/ https://ncbi.nlm.nih.gov/pubmed/31341985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctro.2019.04.012 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|